These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29068569)

  • 1. Role of thiamine in Huntington's disease pathogenesis: In vitro studies.
    Gruber-Bzura BM; Krzysztoń-Russjan J; Bubko I; Syska J; Jaworska M; Zmysłowski A; Rosłon M; Drozd J; Drozd E; Majorczyk E; Anuszewska EL
    Adv Clin Exp Med; 2017 Aug; 26(5):751-760. PubMed ID: 29068569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism.
    Seong IS; Ivanova E; Lee JM; Choo YS; Fossale E; Anderson M; Gusella JF; Laramie JM; Myers RH; Lesort M; MacDonald ME
    Hum Mol Genet; 2005 Oct; 14(19):2871-80. PubMed ID: 16115812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased glucose metabolism and ATP level in brain tissue of Huntington's disease transgenic mice.
    Oláh J; Klivényi P; Gardián G; Vécsei L; Orosz F; Kovacs GG; Westerhoff HV; Ovádi J
    FEBS J; 2008 Oct; 275(19):4740-55. PubMed ID: 18721135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Metabolic Abnormalities in the Tricarboxylic Acid Cycle in Peripheral Cells From Huntington's Disease Patients.
    Naseri NN; Bonica J; Xu H; Park LC; Arjomand J; Chen Z; Gibson GE
    PLoS One; 2016; 11(9):e0160384. PubMed ID: 27611087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin.
    Naia L; Ribeiro M; Rodrigues J; Duarte AI; Lopes C; Rosenstock TR; Hayden MR; Rego AC
    Neuropeptides; 2016 Aug; 58():73-81. PubMed ID: 26876526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiamine Deprivation Produces a Liver ATP Deficit and Metabolic and Genomic Effects in Mice: Findings Are Parallel to Those of Biotin Deficiency and Have Implications for Energy Disorders.
    Hernandez-Vazquez AJ; Garcia-Sanchez JA; Moreno-Arriola E; Salvador-Adriano A; Ortega-Cuellar D; Velazquez-Arellano A
    J Nutrigenet Nutrigenomics; 2016; 9(5-6):287-299. PubMed ID: 28214879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brain.
    Lim NK; Hung LW; Pang TY; Mclean CA; Liddell JR; Hilton JB; Li QX; White AR; Hannan AJ; Crouch PJ
    Hum Mol Genet; 2014 Aug; 23(15):4051-63. PubMed ID: 24634145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative metabolism in YAC128 mouse model of Huntington's disease.
    Hamilton J; Pellman JJ; Brustovetsky T; Harris RA; Brustovetsky N
    Hum Mol Genet; 2015 Sep; 24(17):4862-78. PubMed ID: 26041817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting thiamine-dependent enzymes for metabolic therapies in oral squamous cell carcinoma?
    Grimm M; Calgéer B; Teriete P; Biegner T; Munz A; Reinert S
    Clin Transl Oncol; 2016 Feb; 18(2):196-205. PubMed ID: 26179749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington's disease.
    Ban JJ; Chung JY; Lee M; Im W; Kim M
    Biochem Biophys Res Commun; 2017 Jun; 488(2):316-321. PubMed ID: 28495533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington's Disease.
    Kolli N; Lu M; Maiti P; Rossignol J; Dunbar GL
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glyceraldehyde 3-phosphate dehydrogenase augments the intercellular transmission and toxicity of polyglutamine aggregates in a cell model of Huntington disease.
    Mikhaylova ER; Lazarev VF; Nikotina AD; Margulis BA; Guzhova IV
    J Neurochem; 2016 Mar; 136(5):1052-63. PubMed ID: 26662373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Aggregation of Mutant Huntingtin by Nucleic Acid Aptamers In Vitro and in a Yeast Model of Huntington's Disease.
    Chaudhary RK; Patel KA; Patel MK; Joshi RH; Roy I
    Mol Ther; 2015 Dec; 23(12):1912-26. PubMed ID: 26310631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses of the mitochondrial alpha-ketoglutarate dehydrogenase complex to thiamine deficiency may contribute to regional selective vulnerability.
    Shi Q; Karuppagounder SS; Xu H; Pechman D; Chen H; Gibson GE
    Neurochem Int; 2007 Jun; 50(7-8):921-31. PubMed ID: 17482317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A toxic mutant huntingtin species is resistant to selective autophagy.
    Fu Y; Wu P; Pan Y; Sun X; Yang H; Difiglia M; Lu B
    Nat Chem Biol; 2017 Nov; 13(11):1152-1154. PubMed ID: 28869595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective expression of mutant huntingtin during development recapitulates characteristic features of Huntington's disease.
    Molero AE; Arteaga-Bracho EE; Chen CH; Gulinello M; Winchester ML; Pichamoorthy N; Gokhan S; Khodakhah K; Mehler MF
    Proc Natl Acad Sci U S A; 2016 May; 113(20):5736-41. PubMed ID: 27140644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells.
    Ribeiro M; Rosenstock TR; Cunha-Oliveira T; Ferreira IL; Oliveira CR; Rego AC
    Free Radic Biol Med; 2012 Nov; 53(10):1857-67. PubMed ID: 22982598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xyloketal-derived small molecules show protective effect by decreasing mutant Huntingtin protein aggregates in Caenorhabditis elegans model of Huntington's disease.
    Zeng Y; Guo W; Xu G; Wang Q; Feng L; Long S; Liang F; Huang Y; Lu X; Li S; Zhou J; Burgunder JM; Pang J; Pei Z
    Drug Des Devel Ther; 2016; 10():1443-51. PubMed ID: 27110099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.
    Lu B; Palacino J
    FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.